Cinacalcet normalizes serum calcium in a double- blind randomized, placebo-controlled study in patients with primary hyperparathyroidism with contraindications to surgery

ID:am030003M003523kxtk108194📫 -页
Cinacalcet normalizes serum calcium in a double- blind randomized, placebo-controlled study in patients with primary hyperparathyroidism with contraindications to surgery
⚠ 举报QQ邮箱: 361755509@qq.com⚠ 版权申诉QQ邮箱: 361755509@qq.com

内容摘要

Cinacalcet normalizes serum calcium in a double- blind randomized, placebo-controlled study in patients with primary hyperparathyroidism with contraindications to surgery

海外数据平台所有内容均是公开网络、AI代理代查、客户上传分享、合作方,仅供网友学习交流,请勿商用!

海外数据(小程序)

微信小程序

请使用微信扫码打开小程序